AVTX vs ICU

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 05, 2026

AVTX

58.8
AI Score
VS
AVTX Wins

ICU

31.7
AI Score

Investment Advisor Scores

AVTX

59score
Recommendation
HOLD

ICU

32score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric AVTX ICU Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -69.3% 82.0% ICU
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 58.8/100 31.7/100 AVTX
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

AVTX 1M: -22.5% · 3M: -24.9% ICU 1M: +62.8% · 3M: -1.5%

Current Technical Phase

AVTX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.8%), weak momentum, RSI 35

RSI (14): 34.6 · Price: $14.99

ICU

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 77

RSI (14): 77.5 · Price: $4.69

Fundamentals Snapshot

Metric AVTX ICU
Market Cap — —
Forward P/E -5.5 -2.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.7% 0.8%
Gross Margin -811.7% 0.9%
Operating Margin -1548.5% -6.2%
EPS -4.41 -1.89
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AVTX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.